JPRN-UMIN000006036招募中2 期
Phase II study of Docetaxel, Cisplatin and S1 followed by surgery in advanced gastric cancer with lymph node metastasis of the paraaorta - Paraaorta GC preoperative DCS Phase II
Digestive Disease Support Organization (DDSO)0 个研究点目标入组 30 人开始时间: 2011年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient with clinically obvious infecton 2) Serious complications(cardiac disease, respiratory dysfunction, bleeding disorder, severe HT or DM) 3) Gastric remnant cancer 4) Synchronous or metachronous malignancy in other organs including 5-year disease-free survival 5) Gastric cancer wtih distant metastasis 6) Past history of drug allergy of docetaxel or CDDP or S-1 7,8) Difficulty to join the trial due to psychosis or psychotic symptoms or central nervous system damage 9) Probable pregnancy, and the period of lactation 10)Not fit to the protocol treatment by the physicion's dicision
研究者
相似试验
招募中
2 期
Phase II study of DCS-Tgastric cancerJPRN-jRCTs061180096Takayama Tetsuji30
招募中
不适用
Phase 2 study of S-1, docetaxel, cisplatin and trastuzumab combination chemotherapy (DCS-T) in patients with HER2-positive unresectable metastatic gastric cancergastric cancerJPRN-UMIN000012042Tokushima-Hokkaido cancer therapy clinical trial group30
已完成
1 期
Phase I/II Study of S-1, Cisplatin and Docetaxel in Patients with Advanced Gastric Canceruntreated advanced or recurrent gastric cancerJPRN-UMIN000000484Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama40
已完成
1 期
Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancerGastric cancerJPRN-UMIN000000978Shizuoka Cancer Center18
进行中（未招募）
不适用
Phase II Study of Docetaxel, Oxaliplatin, Capecitabine with Bevacizumab and Trastuzumab in case of human epidermal growth factor receptor 2 (HER2)-positivity inPatients with Locally Advanced or Metastatic Gastric Cancer or Adenocarcinoma of the Gastro-oesophageal Junction (B-DOCT study) - B-DOCT studyocally Advanced or Metastatic Gastric Cancer or Adenocarcinoma of the Gastro-oesophageal JunctionMedDRA version: 12.1Level: PTClassification code 10063916Term: Metastatic gastric cancerMedDRA version: 12.1Level: LLTClassification code 10017758Term: Gastric cancerMedDRA version: 12.1Level: LLTClassification code 10066896Term: HER-2 positive gastric cancerEUCTR2010-022699-30-NLederlands Kanker Instutuut-Antonie van Leeuwenhoek Ziekenhuis